Referencias Bibliográficas Harrison. Principios de medicina interna. Síndrome de Digestivo irritable. Editorial McGraw-Hill 14° edición. Volumen II p 1868-70. 1998. Drossman DA: The Functional Gastrointestinal disorders and the Rome II process. GUT 1999, 45 (suppl 2): 111-115 Jones J, Boorman J, Cann P, et al: British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome. GUT 2000, 47 (suppl 2): 111-119 Thompson WG, Heaton KW, Smyth GT, Smyth C: Irritable Bowel Syndrome in general practice: prevalence, characteristics, and referral. GUT 2000, 46:78-82. Kapoor KK, Nigam P, Rastogi CK, et al: Clinical profile of irritable bowel syndrome. Indian J Gastroenterol 1985, 4:15-16 Delvaux M, Denis P, Allemand H: Sexual abuse is more frequently reported by IBS patients than by patients with organic digestive diseases or controls. Results of a multicentre inquiry. French club of Digestive motility. Eur J Gastroenterol Hepatol 1997, 9:345-352. Bennet EJ, Tennant CC, Piesse C, et al: Level of chronic life stress predicts clinical outcome in irritable bowel síndrome. GUT 1998,43:256-261 Whorwell PJ, Prior A, Colgan SM: Hypnotherapy in severe irritable bowel disease: further experience. GUT 1987, 28:423-425. Spiller RC: Treatment of irritable Bowel Syndrome. C Treat Options Gastroenterol 2003, 6:329-337. Lembo T, Wright Ra, Bagby B, et al: Allosetron controls bowel urgency and provides global symptom improvement in women with diarrhea predominant irritable bowel syndrome. Am J Gastroenterol 2001, 96:2662-2670. Camilleri M: Review article: tegaserod. Aliment Pharmacol Ther 2001, 15 :277-289. Muller – Lissner SA, Famagalli I, Bardhan KD et al : Tegaserod, a 5-HT4 receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001, 15:1655-1666. Clouse RE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant Therapy in 138 patients with irritable bowel syndrome: a five year clinical experience. Aliment Pharmacol Ther 1994, 8:409-416. 118
Poynard T, Regimbeau C, Benhamou Y: Meta- analysis of smoth muscle relaxants in the treatment of irritable bowel syndrome. Gastroenterology 2003. 124:303-317. Nobaek S, Johansson Ml, Molin G, et al: Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000, 95:1231-1238. 119